Stephen William Watt
19Patents
8h-index
27Co-inventors
68Inventor score
Filing activity: Nov 8, 2006 → Jan 31, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8173706B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 31 | Active |
| US8492439B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 29 | Active |
| US8785498B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 27 | Active |
| US8946473B2 | Methods of making L-ornithine phenyl acetate | Chemistry; Metallurgy | 26 | Active |
| US9034925B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 26 | Active |
| US9604909B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 23 | Active |
| US9260379B2 | Methods of making L-ornithine phenyl acetate | Chemistry; Metallurgy | 23 | Active |
| US9623017B2 | 4:3 naltrexone: 5-methyl-2-furaldehyde cocrystal | Chemistry; Metallurgy | 9 | Active |
| US10173964B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 7 | Active |
| US10550069B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 5 | Active |
| US7863325B2 | Crystalline genistein sodium salt dihydrate | Human Necessities | 4 | Active |
| US8653064B2 | Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin-2-yl]amino}-2-methoxybenzoate | Chemistry; Metallurgy | 1 | Active |
| US11161802B2 | L-ornithine phenyl acetate and methods of making thereof | Chemistry; Metallurgy | 1 | Active |
| US7648976B2 | 17-allylamino-17-demethoxygeldanamycin polymorphs and formulations | Human Necessities | 0 | Active |
| US10017513B2 | Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido [5,4-D][2]benzazepin-2-YL]amino}-2-methoxybenzoate | Chemistry; Metallurgy | 0 | Active |
| US11096936B2 | Cocrystals of naloxone and naltrexone | Chemistry; Metallurgy | 0 | Active |
| US9012495B2 | Crystalline forms of genistein | Chemistry; Metallurgy | 0 | Active |
| US10980799B2 | Crystalline salts of naloxone and naltrexone | Chemistry; Metallurgy | 0 | Active |
| US9492425B2 | Crystalline forms of genistein | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.